期刊
ACTA OPHTHALMOLOGICA
卷 93, 期 2, 页码 141-145出版社
WILEY-BLACKWELL
DOI: 10.1111/aos.12535
关键词
age-related macular degeneration; complement system; lutein; sC5b-9
PurposeThe purpose of this study was to investigate the effect of lutein on systemic complement activation in elderly individuals. MethodsSeventy patients with signs of early age-related macular degeneration (AMD) were included in this study. All subjects were randomly assigned to receive a 10mg daily dose of lutein or a placebo for a time period of 1year. EDTA blood was collected before and at various time-points during the study (0, 4, 8 and 12months). The plasma level of the soluble complement membrane attack complex sC5b-9 was measured by ELISA. ResultsWe found a significant 1.1ng/ml monthly decrease in the plasma sC5b-9 concentration in the lutein group (p<0.001), resulting in a decrease from 60.3ng/ml at baseline to 46.3ng/ml at 12months. For the placebo group, we found a significant 0.6ng/ml monthly increase in plasma sC5b-9 concentration (p=0.001), resulting in an increase from 51.6ng/ml at baseline to 58.4ng/ml at 12months. ConclusionsLutein supplementation inhibits the systemic activation of the complement system, which provides further functional evidence for the reported beneficial effects of this carotenoid in the management of AMD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据